Under construction – not a live service
Sign in
Taking peopleNo phase

Multimodal Biocollection Linked to the French Register of Intracranial Aneurysms

Key facts

Who runs it
Nantes University Hospital
Where
France26 sites in 1 countryChoose a country to see its sites
Trial code
Status
Recruiting
People taking part
1,100 people, planned
Started
25 Mar 2025
Expected to end
25 Mar 2027
Type of study
Interventional
Treatments tested
  • blood or saliva sample
Record updated
2 September 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 14 criteriaShow less

Who can take part

  • Any adult patient consulting for a definite and typical bifurcation AIC authenticated on MRI and/or cerebral arteriography
  • Aneurysm discovered less than a year ago, with initial imaging (MRI and/or CTA and DSA) available
  • Written consent obtained for study participation
  • Patient covered by a social security plan
  • Index case: Any adult patient consulting for a definite and typical bifurcation ICA presenting at least one other case with ICA related (child, parent, brother, sister) detected by MRI with at least one Time of Flight (TOF) sequence
  • Family relatives: children, parents, brothers, sisters, of legal age, of patients with a family history of definite, typical bifurcation AIC (≥ 4 affected), Screening to be performed using MRI with at least a Time of Flight (TOF) sequence
  • Written consent to participate in the study
  • Patient and relatives covered by a social security plan

Who cannot take part

  • Syndromic diagnosis known to cause ICA: Marfan syndrome, OSA with SMAD 3, Elhers Danlos syndrome type II and IV, Autosomal Dominant Cystic Fibrosis, Moya-Moya syndrome
  • AIC with : Dissecting or fusiform, Associated with arteriovenous malformation, Blister-like, Mycotic
  • Cerebral white matter pathology detected on MRI evoking : Col4a1 mutation
  • Patient under guardianship or conservatorship
  • Person under court protection
  • Contraindication to an MRI scan

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The purpose of the bCAN study is to create a prospective collection of multimodal data and human samples, linked to the French Intracranial Aneurysm Registry (FRAN).

Read full original descriptionShow less

The aim of bCAN is to enable risk stratification of ruptured ICAs by redefining "intracranial aneurysm disease". The description of genotypically and phenotypically specific subgroups of cases will pave the way for improved patient management based on new diagnostic/prognostic strategies among AIC carriers, either in a familial context, or at the level of the general population.

The group in the trial

  • ICA casesOther group

    Any adult patient consulting for a definite and typical bifurcation AIC authenticated on MRI and/or cerebral arteriography

    Treatment: blood or saliva sample

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Record updated
2 September 2026